This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Fast track cell, gene & car-t commercialization from concept to robust patient-centric delivery.

Cell and Gene Therapy Supply Chain and Raw Materials: Lessons from a Pandemic

Share this article

The COVID-19 pandemic has had expansive effects on the Gene and Cell Therapy industry, including accelerating the development of viral vector technology. The pandemic has also posed new challenges to the industry's supply chain. Read our newly-released eBook which dives into the post-pandemic supply chain challenges that the industry faces, including an overview of the effects on different supply chain components; Thermo Fisher's CAR T cells manufacturing practices using a GMP-compliant modular workflow that reduces manual cell processing in manufacturing workflows; and an overview of the BioProcess Insider roundtable discussion between different subject matter experts on the post-pandemic effects on the supply chain and what lessons the industry should carry forward to improve supply chain stability and manufacturing practices.

Share this article

Upcoming event

Cell & Gene Therapy Manufacturing & Commercialization Asia

11 - 14 Apr 2022, Presented in Japan Standard Time (JST)
The ONLY Cell and Gene Therapy event in Asia to help you fast track manufacturing & commercialization across borders
Go to site